Jorey Chernett has bought stock on 10 days since May 2026

Chernett Jorey (also reported as Jorey Chernett) is a significant individual shareholder and 10% owner of The Oncology Institute, Inc. (NASDAQ: TOI), a value‑based oncology care provider in the United States.( He first appeared in TOI’s ownership disclosures via a Schedule 13G filing reporting beneficial ownership of 5,114,944 shares, or approximately 5.2% of the company’s common stock as of an event dated January 14, 2026, with sole voting and dispositive power over all reported shares.( Subsequently, he filed an initial Form 3 with the U.S. Securities and Exchange Commission in March 2026, formally identifying himself as an insider of The Oncology Institute.(

Following his initial passive stake, Chernett has increased his holdings through multiple open‑market purchases, including a Form 4‑reported acquisition of 25,000 TOI shares at a weighted average price of about $3.35 per share and another reported purchase of 20,000 shares at $3.10 per share.( After these transactions, he directly owned more than 10 million shares of The Oncology Institute, solidifying his status as a major outside investor and 10% owner.( Public filings and transaction reports describe him solely in the context of his investment and insider ownership; they do not provide additional detail about his professional career, operating roles, or educational background beyond his status as a large individual shareholder, nor do they indicate that he is a company or investment firm.(

Written by Perplexity from public sources.